本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fortress Biotech Inc Series A P

14.40
+0.04000.28%
盘后14.400.00000.00%16:00 EST
成交量:4.10万
成交额:57.63万
市值:4,935.02万
市盈率:-49.15
高:14.50
开:14.20
低:13.79
收:14.36
52周最高:14.50
52周最低:4.72
股本:342.71万
流通股本:342.71万
量比:0.67
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-0.2930
每股收益(LYR):-2.6890
净资产收益率:-746.25%
总资产收益率:-32.37%
市净率:2.22
市盈率(LYR):-5.36

数据加载中...

2024/01/27

重要事件披露

Form 8-K - Current report
2024/01/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/11/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/27

SEC问询函

Form CORRESP - Correspondence
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/19

SEC问询函

Form CORRESP - Correspondence
2023/07/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/23

重要事件披露

Form 8-K - Current report